Tumor progression—targets for differential therapy
AB Pardee - Journal of cellular physiology, 2006 - Wiley Online Library
Differential killing of the patient's cancer cells versus normal cells is a necessity for
chemotherapy. Advantage can be taken of close regulations of gene expression and of …
chemotherapy. Advantage can be taken of close regulations of gene expression and of …
Tumor progression--targets for differential therapy
AB Pardee - Journal of cellular physiology, 2006 - pubmed.ncbi.nlm.nih.gov
Differential killing of the patient's cancer cells versus normal cells is a necessity for
chemotherapy. Advantage can be taken of close regulations of gene expression and of …
chemotherapy. Advantage can be taken of close regulations of gene expression and of …
Tumor progression--targets for differential therapy.
AB Pardee - Journal of Cellular Physiology, 2006 - europepmc.org
Differential killing of the patient's cancer cells versus normal cells is a necessity for
chemotherapy. Advantage can be taken of close regulations of gene expression and of …
chemotherapy. Advantage can be taken of close regulations of gene expression and of …